Syed Kazmi, M.D.

@PatricioPolanc0 He must be proud of your accomplishments.

Over 20 years ago, my dad was named an honorary member of the Peruvian Surgery Society for his contributions to the Peruvian surgical community. A few days ago, I was deeply honored to receive the same recognition. I wish he were here to see it. Te extraño papá.

County-Based financial assistance programs is associated with improved survival in pancreas & liver cancer.Great work by @UTSWSurgeryLife resident @KMuhammadSohaib for our group on @JNCI_Now Financial assistance programs for low income pts likely more important in states without Medicaid expansion. @UTSWMedCenter @UTSW_Surgery @Parkland academic.oup.com/jncics/advance…

In a new study published in @AdvPortfolio, #UTSW researchers found that chronic inflammation increased colon stiffness, driving the development and growth of early-onset colorectal cancer – offering new insights into prevention and treatment strategies. bit.ly/4paloRJ

NCI9673 (Part B), now in @JCO_ASCO: Addition of ipi to nivo did not improve survival for pts w/ met anal cancer. With that said, 👏 @theNCI ETCTN for acccruing largest comparative IO RCT to date for met anal cancer 👏 pts for participating -> trials for rare cancers ARE feasible to complete 👏 @theNCI for trial support -> unmet need to do better for anal cancer pts remains 👏 @CathyEngMD for leadership, and 👏 @MDAndersonNews team for 💪 accrual and commitment to translational science We keep moving on to do better and #endcancer for anal cancer… please come join the collaborative team! ascopubs.org/doi/10.1200/JC…

Before Thanksgiving, our colorectal surgery team stepped onto the helipad for a quiet moment of wellness and a beautiful sunset. 🌇 Grateful for the dedicated hands, the meaningful work, and the teamwork that make every day possible. ❤️ #UTSWSurgery #UTSW

If Exercise Were a Pill, We'd All Prescribe It to Patients With Cancer. But It's Not | Journal of Clinical Oncology ascopubs.org/doi/10.1200/JC…

Representative case of zolbetuximab-induced gastritis that improved despite continued treatment. A case series with additional patients will be coming soon. esmogastro.org/article/S2949-… @OncoAlert @myESMO

Thrilled to see @ASCO guidelines recommending exercise for patients w/ cancer highlighted in the new @WhiteHouse factsheet. Exercise during cancer treatment can improve cardiorespiratory fitness, strength, fatigue & may improve patient's quality of life.➡️ascopubs.org/doi/full/10.12…

👋Join us 10/19-10/20 in #Dallas for @GreatDebatesCME w/my co-Chair @YJanjigianMD and 🤩faculty @mgibson21212 @NataliyaUboha @HHampel1 @doctormikehall @KristenCiombor @smitha42 @rachnatshroff @JavleMilind @GABOUALFA @adasarimd @HKennecke @ArdamanShergil1 @PrajnanDasMD @SyedKazmiMD @MallaMidhun #cancer #CancerResearch GREAT group! hmpglobalevents.com/gdugi

@TimothyJBrownMD better late than never.

2024 is absolutely wild

Addition of Nintedenib to gem/abr was safe and well tolerated in a phase 1 trial of mPDAC. Congrats @Salthecancerguy on the #ESMOGI24 presentation. @ShaalanBeg @SyedKazmiMD @drnileshverma

As @ASCO winds down, I want to thank the late Dr. Waun Ki Hong for being an unbelievable mentor and supporter for so many who are now leading cancer breakthroughs. We were fortunate to have him cheering us on (then and now). @MDAndersonNews cancerletter.com/in-the-archive…

Baqir Jafry did an excellent job presenting real-world data in pancreatic cancer under the guidance of one of our most promising young faculty, Dr. Tim Brown.

In stage 3, adjuvant chemo significantly improved overall survival regardless of MSI-status and risk-stratication

In a propensity score matched, landmark analysis of NCDB (matched for age, gender & comorbidities), we confirm that "low & high-risk stage 2" MSI-H CRC had a trend towards a lower overall survival with adjvuvant chemo. doi.org/10.1016/j.jncc…

@Dr_R_Kurzrock Thank you Drs. Kurzrock and Hong, for this excellent contribution. It will come in handy soon, when I meet with our leadership to advocate for our phase 1 program

I really enjoyed writing this piece with David Hong. The MD Anderson Cancer Center phase I dept that I founded/built is one of the largest and best in the world. Kudos to Funda and David for continuing to grow/strengthen it. The principles for success are counterintuitive.

Learn "How to Build a Successful Phase I Clinical Trials Unit", with customized tips from Drs Razelle Kurzrock and David Hong. doi.org/10.36401/JIPO-… #phase1 #oncology @MDAndersonNews @Dr_R_Kurzrock

Published today! 📰 @NatureMedicine One of the first #cancer vaccines💉that target #KRAS. Not just G12C. 👇🏾The 2-peptide was G12D & R. The 7-Peptide/Elicio targets D R V S A C G13 ➕ NRAS Implications for so many patients! Open now. Cheers! @OncoAlert nature.com/articles/s4159…

#ESMO23 Presidential session talk by @tompowles1 👉1st time in >30 years, a Rx regimen shows superiority to cisplatin based Rx in mUC #bladdercancer : Enfortumab + pembrolizumab combo vs platinum based Rx👉55% and 53% reduction in risk of progression and death with combo👇 @OncoAlert @urotoday @Uromigos

🗞️Just published @JCOPO_ASCO At the intersection of Liquid Biopsies🔄Precision Medicine Pan-cancer assessment of ✅PLASMA🩸MSI-High and assessment of real-world outcomes. 👉🏾1.4% of 171,881 patients. 💡If shed, 🧬#ctDNA MSI reliable. @OncoAlert @ASCO ascopubs.org/doi/full/10.12…